Your browser doesn't support javascript.
loading
SPOP targets the immune transcription factor IRF1 for proteasomal degradation.
Schwartz, Irene; Vunjak, Milica; Budroni, Valentina; Cantoran García, Adriana; Mastrovito, Marialaura; Soderholm, Adrian; Hinterndorfer, Matthias; de Almeida, Melanie; Hacker, Kathrin; Wang, Jingkui; Froussios, Kimon; Jude, Julian; Decker, Thomas; Zuber, Johannes; Versteeg, Gijs A.
Afiliación
  • Schwartz I; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna, Austria.
  • Vunjak M; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna Biocenter, Vienna, Austria.
  • Budroni V; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna, Austria.
  • Cantoran García A; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna Biocenter, Vienna, Austria.
  • Mastrovito M; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna, Austria.
  • Soderholm A; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna Biocenter, Vienna, Austria.
  • Hinterndorfer M; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna, Austria.
  • de Almeida M; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna, Austria.
  • Hacker K; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna, Austria.
  • Wang J; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna Biocenter, Vienna, Austria.
  • Froussios K; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna Biocenter, Vienna, Austria.
  • Jude J; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
  • Decker T; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna Biocenter, Vienna, Austria.
  • Zuber J; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
  • Versteeg GA; Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna, Austria.
Elife ; 122023 08 25.
Article en En | MEDLINE | ID: mdl-37622993
ABSTRACT
Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription factor in driving the expression of immune response genes during infection. The striking difference in functional output with other IRFs is that IRF1 also drives the expression of various cell cycle inhibiting factors, making it an important tumor suppressor. Thus, it is critical to regulate the abundance of IRF1 to achieve a 'Goldilocks' zone in which there is sufficient IRF1 to prevent tumorigenesis, yet not too much which could drive excessive immune activation. Using genetic screening, we identified the E3 ligase receptor speckle type BTB/POZ protein (SPOP) to mediate IRF1 proteasomal turnover in human and mouse cells. We identified S/T-rich degrons in IRF1 required for its SPOP MATH domain-dependent turnover. In the absence of SPOP, elevated IRF1 protein levels functionally increased IRF1-dependent cellular responses, underpinning the biological significance of SPOP in curtailing IRF1 protein abundance.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / Genes Reguladores Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulación de la Expresión Génica / Genes Reguladores Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Austria